3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
11
Breast
3
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Lung Neoplasms
20
Carcinoma, Non-Small-Cell Lung
20
Small Cell Lung Carcinoma
3
Esophageal Neoplasms
3
Salivary Gland Neoplasms
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Neoplasms
2
Mouth Neoplasms
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Breast Neoplasms
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Tobacco Use Disorder
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Precancerous Conditions
1
Pleural Effusion, Malignant
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Interventions
Paclitaxel
12
pembrolizumab
7
Carboplatin
7
Cisplatin
6
Docetaxel
5
sargramostim
4
Taxes
4
Cyclophosphamide
4
Amifostine
4
Trastuzumab
3
Polymerase Chain Reaction
3
Nivolumab
3
Irinotecan
3
Gemcitabine
3
Etoposide
3
talazoparib
2
aldesleukin
2
Vorinostat
2
Vinorelbine
2
SS1(dsFv)PE38
2
Pemetrexed
2
Interleukin-12 Subunit p35
2
Interleukin-12
2
Immunoenzyme Techniques
2
Gene Expression Profiling
2
Flow Cytometry
2
Filgrastim
2
Erlotinib Hydrochloride
2
tocilizumab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Immunohistochemistry
×
Thoracic
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled